Stocktoria
Bon Natural Life Ltd BON
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-06-24
Bon Natural Life Ltd financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $18.7M | $23.8M | $29.5M | $29.9M | $25.5M |
| Gross profit | $3.9M | $7.1M | $8.8M | $9.4M | $7.1M |
| R&D expense | $754,193 | $1.6M | $298,469 | $424,558 | $249,050 |
| Operating income | -$1.6M | $1.9M | $5.9M | $6.6M | $5.4M |
| Interest expense | $366,180 | $303,325 | $238,224 | $446,884 | $417,266 |
| Income tax | $339,414 | $351,179 | $1.0M | $1.3M | $820,931 |
| Net income | -$2.0M | $398,172 | $4.6M | $6.2M | $4.6M |
| EPS (diluted) | $-0.72 | $4.14 | $124.92 | $7.43 | $0.68 |
| Operating cash flow | $141,115 | -$7.7M | $6.3M | -$187,121 | $4.1M |
| Free cash flow | $134,288 | -$7.7M | $6.3M | -$214,816 | $4.0M |
| Cash & equivalents | — | $80,466 | — | — | — |
| Inventory | $3.3M | $1.6M | $987,287 | $1.7M | $1.6M |
| Total assets | $85.2M | $61.8M | $46.6M | $37.3M | $36.4M |
| Total liabilities | $27.2M | $17.4M | $10.6M | $7.2M | $9.9M |
| Shareholders' equity | $58.0M | $44.3M | $36.0M | $30.1M | $26.5M |
Source: SEC EDGAR filings · CIK 0001816815 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.